🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is a multi-center, open-label, phase I, dose escalation study of...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT02884128
The purpose of this study is to assess objective tumor response in the sing...
Status
Completed
Location
Clinical Hospital Mostar
Start Date
2007-11
Trial ID
NCT00813072
Treatments Being Tested
The purpose of this study is to see the effect of PEP02 in the treatment of...
Status
Completed
Location
Comprehensive Cancer Center, UCSF
Start Date
2009-01
Trial ID
NCT00813163
Treatments Being Tested
This phase II trial tests how well liposomal irinotecan, oxaliplatin, 5-flu...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2026-03-02
Trial ID
NCT06821997
This phase I/II trial studies the side effects and best dose of MM-398 and ...
Status
Withdrawn
Location
USC / Norris Comprehensive Cancer Center
Start Date
2020-04-06
Trial ID
NCT03739801
Treatments Being Tested
This phase II trial compares two treatment combinations: gemcitabine hydroc...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-08-26
Trial ID
NCT04233866
This study is to assess the anti-tumour activity, safety and tolerability o...
Status
Completed
Location
National Cancer Center Hospital East (003)
Start Date
2024-04-25
Trial ID
NCT06225999
The study is an open label, randomized phase 3 study of MM-398 with or with...
Status
Completed
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01494506
Treatments Being Tested
This phase III trial compares the effect of adding panitumumab to standard ...
Status
Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2026-05-13
Trial ID
NCT06998940
Multicenter open-label, phase II trial, to evaluate the efficacy and safety...
Status
Completed
Location
ICO
Start Date
2017-05-02
Trial ID
NCT03328884
Treatments Being Tested